TY - JOUR
T1 - Asthma medication adherence
T2 - The role of God and other health locus of control factors
AU - Ahmedani, Brian K.
AU - Peterson, Edward L.
AU - Wells, Karen E.
AU - Rand, Cynthia S.
AU - Williams, L. Keoki
N1 - Funding Information:
Funding Sources: This research was supported by grants from the American Asthma Foundation ; the Fund for Henry Ford Hospital ; and the National Institute of Allergy and Infectious Diseases ( R01AI079139 , R01AI061774 ), the National Heart Lung and Blood Institute ( R01HL079055 ), and the National Institute of Diabetes and Digestive and Kidney Diseases ( R01DK064695 ), National Institutes of Health . These funding agencies did not have a role in the study design, analysis, drafting of the manuscript, or revision of the manuscript. All authors declare no other support for the submitted work.
PY - 2013/2
Y1 - 2013/2
N2 - Background: Medication adherence is an important determinant of disease outcomes, yet medication use on average tends to be low among patients with chronic conditions, including asthma. Although several predictors of non-adherence have been assessed, more research is needed on patients' beliefs about God and how these relate to medication use. Objective: To examine the relationship between perceptions about «God's» role in health and other locus of control factors with inhaled corticosteroid (ICS) adherence among asthma patients. Methods: Participants were from a clinical trial to improve ICS adherence and were 5-56 years old, had a diagnosis of asthma, and were receiving ICS medication. Baseline adherence was estimated from electronic prescription and pharmacy fill records. Patients were considered to be adherent if ICS use was ≥80% of prescribed. A baseline survey with the Multidimensional Health Locus of Control scale was used to assess five sources (God, doctors, other people, chance, and internal). Results: Medication adherence was low (36%). Patients' who had a stronger belief that God determined asthma control were less likely to be adherent (odds ratio [OR] 0.82, 95% confidence interval [CI] 0.70-0.96). This relationship was stronger among African American (OR 0.68, 95% CI0.47-0.99) compared to white patients (OR 0.89, 95% CI 0.75-1.04), and among adults (OR 0.81, 95% CI 0.69-0.96) compared to children (OR 0.84, 95% CI 0.58-1.22). Conclusion: Patients' belief in God's control of health appears to be a factor in asthma controller use, and therefore should be considered in physician-patient discussions concerning course of treatment.
AB - Background: Medication adherence is an important determinant of disease outcomes, yet medication use on average tends to be low among patients with chronic conditions, including asthma. Although several predictors of non-adherence have been assessed, more research is needed on patients' beliefs about God and how these relate to medication use. Objective: To examine the relationship between perceptions about «God's» role in health and other locus of control factors with inhaled corticosteroid (ICS) adherence among asthma patients. Methods: Participants were from a clinical trial to improve ICS adherence and were 5-56 years old, had a diagnosis of asthma, and were receiving ICS medication. Baseline adherence was estimated from electronic prescription and pharmacy fill records. Patients were considered to be adherent if ICS use was ≥80% of prescribed. A baseline survey with the Multidimensional Health Locus of Control scale was used to assess five sources (God, doctors, other people, chance, and internal). Results: Medication adherence was low (36%). Patients' who had a stronger belief that God determined asthma control were less likely to be adherent (odds ratio [OR] 0.82, 95% confidence interval [CI] 0.70-0.96). This relationship was stronger among African American (OR 0.68, 95% CI0.47-0.99) compared to white patients (OR 0.89, 95% CI 0.75-1.04), and among adults (OR 0.81, 95% CI 0.69-0.96) compared to children (OR 0.84, 95% CI 0.58-1.22). Conclusion: Patients' belief in God's control of health appears to be a factor in asthma controller use, and therefore should be considered in physician-patient discussions concerning course of treatment.
UR - http://www.scopus.com/inward/record.url?scp=84873158597&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84873158597&partnerID=8YFLogxK
U2 - 10.1016/j.anai.2012.11.006
DO - 10.1016/j.anai.2012.11.006
M3 - Article
C2 - 23352524
AN - SCOPUS:84873158597
SN - 1081-1206
VL - 110
SP - 75-79.e2
JO - Annals of Allergy, Asthma and Immunology
JF - Annals of Allergy, Asthma and Immunology
IS - 2
ER -